Protocols
1 protocol(s) meet the specified criteria
Drug: INCB057643
Protocol No.TitleStatus
INCB57643-101A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB057643 in Subjects with Advanced MalignanciesOpen